Skip to content

Efficacy and safety of ciprofol for the induction and maintenance of general anaesthesia in thoracoscopic surgery

Efficacy and safety of ciprofol for the induction and maintenance of general anaesthesia in thoracoscopic surgery

Status
Recruiting
Phases
Phase 3
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400082924
Enrollment
Unknown
Registered
2024-04-11
Start date
2024-05-01
Completion date
Unknown
Last updated
2024-04-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Thoracic diseases

Interventions

Ciprofol group:Anesthesia induction at 0.4 mg/kg, anesthesia maintained at an initial pump rate of 0.8 mg/kg/h, with each fluctuation of 0.1-0.4 mg/kg/h, and overall control at 0.8-2.4 mg/kg/h
Propofol gruop:Anesthesia induction 2.0 mg/kg, anesthesia maintained at an initial pump speed of 6mg/kg/h, with each fluctuation of 1-2 mg/kg/h, and overall control at 4-12 mg/kg/h

Sponsors

Fuyang Normal University Second Affiliated Hospital (Fuyang Fifth People’ s Hospital)
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: (1) Age 18-75; (2) ASA class II-III; (3) Body mass index (BMI) 18.5-27.9kg/m2; (4) Patients scheduled for thoracoscopic surgery; (5) No history of relevant drug allergies.

Exclusion criteria

Exclusion criteria: (1) History of mental and neurological disorders (such as cerebrovascular disease, epilepsy, senile dementia, schizophrenia, and depression) (2) Patients with multiple chronic diseases who cannot tolerate surgical anesthesia (3) Severe heart, lung, and kidney dysfunction (4) Recently, there has been a history of using drugs such as cyclophosphamide and propofol (5) Individuals with a history of drug allergies and contraindications (6) Patients with alcohol or drug abuse within 3 months

Design outcomes

Secondary

MeasureTime frame
Fluid replacement volume;Blood loss volume;Urine volume;Number of times vasoactive drugs are used during surgery;

Primary

MeasureTime frame
Modified observer's assessment of alert / sedation;Bispectral index;Changes in blood pressure during surgery;Pulse oximetry;Heart rate;Wake-up time;Reatment emergent adverse events;Number of successful and failed anesthesia induction attempts;Number of successful and failed attempts in maintaining anesthesia;Number of drug additions during induction phase;

Countries

China

Contacts

Public ContactYaodong Yan

Fuyang Normal University Second Affiliated Hospital (Fuyang Fifth People’ s Hospital)

5321076@qq.com+86 153 9966 3650

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026